Systemic Treatment of Sarcoidosis

被引：4

作者：

Murray, Philip I. ^{[1
]}

Bodaghi, Bahram ^{[2
]}

Sharma, Om P. ^{[3
]}

机构：

[1] Univ Birmingham, Birmingham, W Midlands, England

[2] Grp Hosp Pitie Salpetriere, Dept Ophthalmol, F-75634 Paris, France

[3] Univ So Calif, Keck Sch Med, Div Pulm & Crit Care, Los Angeles, CA 90033 USA

来源：

OCULAR IMMUNOLOGY AND INFLAMMATION | 2011年 / 19卷 / 02期

关键词：

extraocular; intraocular; RCT; sarcoidosis; treatment; PULMONARY SARCOIDOSIS; DOUBLE-BLIND; INHALED BUDESONIDE; CORTICOSTEROID-THERAPY; CHLOROQUINE THERAPY; RANDOMIZED-TRIAL; INFLIXIMAB; METHOTREXATE; EFFICACY;

D O I：

10.3109/09273948.2010.542870

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Methods: Medline and EMBASE literature search on ""sarcoidosis AND treatment"", ""sarcoidosis AND uveitis AND treatment"", and ""sarcoidosis AND eye AND treatment"". The search was limited to randomized controlled trials (RCTs) and meta-analyses. Results: A total of 19 RCTs for the systemic treatment of extraocular sarcoidosis were identified. The majority were on corticosteroid--oral and inhaled. There were two meta-analyses on corticosteroid, including a Cochrane review. Only two RCTs were indentified for the treatment of intraocular sarcoidosis, one on etanercept, and the other from 1967 on prednisolone or oxyphenbutazone vs. placebo. There were no meta-analyses. Due to the paucity of RCTs other treatment studies were included but these were limited to only a few immunosuppressive agents and on small numbers of patients. Conclusion: Limited high-quality evidence exists for the systemic treatment of sarcoidosis, in particular intraocular disease.

引用

页码：145 / 150

页数：6

共 45 条

[1]

ALBERTS C, 1995, EUR RESPIR J, V8, P682

[2] Randomized trial of prolonged chloroquine therapy in advanced pulmonary sarcoidosis [J].

Baltzan, M ;

Mehta, S ;

Kirkham, TH ;

Cosio, MG .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (01) :192-197

[3] Treatment of sarcoidosis [J].

Baughman, Robert P. ;

Costabel, Ulrich ;

du Bois, Ronald M. .

CLINICS IN CHEST MEDICINE, 2008, 29 (03) :533-+

[4] Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement [J].

Baughman, Robert P. ;

Drent, Marjolein ;

Kavuru, Mani ;

Judson, Marc A. ;

Costabel, Ulrich ;

du Bois, Roland ;

Albera, Carlo ;

Brutsche, Martin ;

Davis, Gerald ;

Donohue, James F. ;

Mueller-Quernheim, Joachim ;

Schlenker-Herceg, Rozsa ;

Flavin, Susan ;

Lo, Kim Hung ;

Oemar, Barry ;

Barnathan, Elliot S. .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 174 (07) :795-802

[5]

Baughman RP, 2005, CHEST, V128, P1062, DOI 10.1378/chest.128.2.1062

[6]

Baughman RP, 2000, SARCOIDOSIS VASC DIF, V17, P60

[7]

Baughman RP, 1997, SARCOIDOSIS VASC DIF, V14, P121

[8] Mycophenolate Mofetil Therapy for Sarcoidosis-Associated Uveitis [J].

Bhat, Pooja ;

Cervantes-Castaneda, Rene A. ;

Doctor, Priyanka P. ;

Anzaar, Fahd ;

Foster, C. Stephen .

OCULAR IMMUNOLOGY AND INFLAMMATION, 2009, 17 (03) :185-190

[9]

CASTRO ED, 2002, ARCH SOC ESP OFTALMO, V77, P301

[10] Methotrexate treatment for sarcoid-associated panuveitis [J].

Dev, S ;

McCallum, RM ;

Jaffe, GJ .

OPHTHALMOLOGY, 1999, 106 (01) :111-118

← 1 2 3 4 5 →